Effects of atorvastatin and aspirin on post-stroke epilepsy and usage of levetiracetam

Abstract Objective: Atorvastatin and aspirin have been used in treating different forms of epilepsy. However, their effect on post-stroke epilepsy (PSE) still needs to be validated by large-scale clinical studies. In addition, their impact on the use of the antiepileptic drug levetiracetam for post-stroke epilepsy remains to be explored. Thus, the aim of this study was to further evaluate the effect of atorvastatin and aspirin on PSE and their effect on the usage of the antiepileptic drug levetiracetam in PSE patients. Methods: Patients, aged 65 to 85 years, with newly diagnosed post-ischemic stroke epilepsy from August 30, 2014 to August 30, 2018 were included in the study, with the exclusion of those with coexisting conditions. Results: Initially, 1321 patients were included, and 780 remained in the study at the 1-year follow-up. During the study, atorvastatin treatment with or without aspirin reduced the number of clinical epileptic episodes in PSE patients. It also reduced the dosage of levetiracetam and achieved better control of epilepsy compared to levetiracetam mono-treatment. Aspirin co-treatment with levetiracetam did not result in a significant improvement. However, the combination of aspirin with atorvastatin significantly reduced the number of seizures compared to atorvastatin treatment alone. Conclusion: Atorvastatin and aspirin co-treatment with levetiracetam can reduce epilepsy in PSE patients and reduce the dosage of levetiracetam required for effective control of PSE.

[1]  D. Ekstein,et al.  Treatment with antiepileptic drugs in patients with stroke. A change in clinical practice may be required , 2018, Journal of the Neurological Sciences.

[2]  I. Jafari Anarkooli,et al.  Neuroprotective effect of lovastatin through down-regulation of pro-apoptotic Mst1 gene expression in rat model pilocarpine epilepsy , 2018, Neurological research.

[3]  D. Malone,et al.  An update on the prevalence and incidence of epilepsy among older adults , 2018, Epilepsy Research.

[4]  M. Ihara,et al.  Post-stroke epilepsy , 2017, Neurochemistry International.

[5]  Yong Liu,et al.  Aspirin attenuates spontaneous recurrent seizures in the chronically epileptic mice , 2017, Neurological research.

[6]  G. Bertini,et al.  Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy , 2017, Epilepsy Research.

[7]  S. Jacob,et al.  An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs , 2016, Drugs in R&D.

[8]  A. Constanti,et al.  Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions. , 2015, Current drug targets.

[9]  R. Dingledine,et al.  Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus , 2015, Neurobiology of Disease.

[10]  E. Kılıç,et al.  HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS , 2015, Neuroscience.

[11]  C. Sila,et al.  Seizures in Ischemic Stroke , 2015 .

[12]  A. Davey,et al.  Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System , 2014, International journal of molecular sciences.

[13]  R. Sankar,et al.  Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain , 2013, Journal of Neuroinflammation.

[14]  Patrick Kwan,et al.  Epilepsy in later life , 2009, The Lancet Neurology.

[15]  C. Tasca,et al.  Atorvastatin Prevents Hippocampal Cell Death due to Quinolinic Acid-Induced Seizures in Mice by Increasing Akt Phosphorylation and Glutamate Uptake , 2009, Neurotoxicity Research.

[16]  A. Dolga,et al.  Statins: Mechanisms of neuroprotection , 2009, Progress in Neurobiology.

[17]  B. Bourgeois,et al.  Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies , 2008, Epilepsia.

[18]  O. Hurtado,et al.  Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection , 2008, Stroke.

[19]  D. Bourke,et al.  An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. , 2006, The American journal of psychiatry.

[20]  P. Duquette,et al.  Statins reduce human blood–brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosis , 2006, Annals of neurology.